Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,891.00
Bid: 2,879.00
Ask: 2,881.00
Change: 49.00 (1.72%)
Spread: 2.00 (0.069%)
Open: 2,853.00
High: 2,891.00
Low: 2,846.00
Prev. Close: 2,842.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Action valuation

30 Jun 2016 07:00

RNS Number : 7191C
3i Group PLC
30 June 2016
 

30 June 2016

 

 

3i Group plc

Update on Action valuation

Since the publication of 3i Group plc's ("3i" or "the Group") financial results for the year to 31 March 2016, 3i has received a number of approaches in respect of Action, the Group's largest portfolio investment.

 

Action continues to grow strongly and, based on trading to mid-June, is performing on a trajectory similar to its 2015 performance with a similar level of like-for-like sales growth. Action is currently also on track to open materially more new stores this year than it did last year.

 

In light of the third-party interest in Action and its continuing growth and financial trajectory, the Board of 3i has decided to increase the book value of its investment in Action to £1,464 million1 after liquidity discount as at 30 June 2016 (31 March 2016: £902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162. The book valuation of £1,464 million amounts to a less than 15x projected run-rate EBITDA as at 31 December 20162 on the assumption that Action continues to grow on its current trajectory for the remainder of this calendar year.

 

3i is actively engaged in the further development of Action and is not intending to sell its investment or organise a flotation of Action in the near future.

 

We will publish our Q1 performance update on 27 July 2016, which will include this adjustment and the results of our quarterly portfolio valuation.

 

Notes

1. Action's valuation currency is euros. The GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.2168:£1.

 

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to £1,464 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016. The valuation as at 31 March 2017 will be calculated using run-rate earnings to 31 December 2016.

 

- Ends -

 

For further information, please contact:

 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

 

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

The financial information in this update is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Although this update has been prepared based on reasonable assumptions, any statements about the future outlook of 3i or its investments may be influenced by factors that could cause actual outcomes and results to be materially different.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUGPQUPQGRB
Date   Source Headline
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20234:12 pmRNSDirector/PDMR Shareholding
31st May 20234:36 pmRNSTotal Voting Rights
31st May 20234:33 pmRNSDirector/PDMR Shareholding
24th May 202310:24 amRNSDoc re. 2023 Notice of AGM
18th May 202311:02 amRNSDoc re. 2023 Annual Report and Accounts
12th May 20232:47 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSResults for the year to 31 March 2023
28th Apr 20234:41 pmRNSTotal Voting Rights
28th Apr 20234:40 pmRNSDirector/PDMR Shareholding
3rd Apr 202310:38 amRNSPortfolio Update
31st Mar 20234:37 pmRNSTotal Voting Rights
31st Mar 20234:34 pmRNSDirector/PDMR Shareholding
28th Mar 202311:36 amRNSDirector/PDMR Shareholding
24th Mar 20232:13 pmRNSDirector/PDMR Shareholding
24th Mar 202312:14 pmRNSDirector/PDMR Shareholding
24th Mar 202312:11 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSAction Capital Markets Seminar & portfolio update
15th Mar 20232:53 pmRNSHolding(s) in Company
28th Feb 20233:41 pmRNSDirector/PDMR Shareholding
28th Feb 20233:31 pmRNSTotal Voting Rights
10th Feb 20231:28 pmRNSHolding(s) in Company
8th Feb 20239:54 amRNSHolding(s) in Company
6th Feb 20232:10 pmRNSDirector/PDMR Shareholding
2nd Feb 202310:44 amRNSDirector/PDMR Shareholding
1st Feb 20233:32 pmRNSDirector/PDMR Shareholding
31st Jan 20234:32 pmRNSTotal Voting Rights
31st Jan 20234:30 pmRNSDirector/PDMR Shareholding
26th Jan 20237:00 amRNS3i Group plc FY2023 Q3 performance update
25th Jan 20233:57 pmRNSHolding(s) in Company
4th Jan 20234:42 pmRNSTotal Voting Rights
4th Jan 20234:41 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSPortfolio Update
30th Dec 20228:10 amRNSDirector Declaration
20th Dec 202210:54 amRNSHolding(s) in Company
19th Dec 20222:52 pmRNSHolding(s) in Company
9th Dec 202212:04 pmRNSBlock listing Interim Review
7th Dec 202212:09 pmRNSAdditional Listing
2nd Dec 202210:51 amRNSHolding(s) in Company
30th Nov 20224:15 pmRNSTotal Voting Rights
30th Nov 20224:09 pmRNSDirector/PDMR Shareholding
10th Nov 20229:02 amRNSDoc re. Half Yearly Report 2022
10th Nov 20227:00 amRNSResults for the six months to 30 September 2022
31st Oct 20224:14 pmRNSTotal Voting Rights
31st Oct 20224:14 pmRNSDirector/PDMR Shareholding
4th Oct 20221:08 pmRNSPortfolio Update
30th Sep 20224:08 pmRNSTotal Voting Rights
30th Sep 20224:00 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSUpdate on portfolio and Capital Markets Seminar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.